| Assay ID | Title | Year | Journal | Article |
|---|
| AID1487211 | Inhibition of human IDO1 pre-incubated for 10 mins before L-Trp as substrate addition and measured after 30 mins by colorimetry | 2017 | Bioorganic & medicinal chemistry letters, 08-01, Volume: 27, Issue:15
| Synthesis of 4- and 5-arylthiazolinethiones as inhibitors of indoleamine 2,3-dioxygenase. |
| AID1487209 | Inhibition of human IDO1 at 100 uM pre-incubated for 10 mins before L-Trp as substrate addition and measured after 30 mins by colorimetry | 2017 | Bioorganic & medicinal chemistry letters, 08-01, Volume: 27, Issue:15
| Synthesis of 4- and 5-arylthiazolinethiones as inhibitors of indoleamine 2,3-dioxygenase. |
| AID443998 | Cytotoxicity against mouse P815B cells expressing mouse recombinant IDO by MTT assay | 2010 | Journal of medicinal chemistry, Feb-11, Volume: 53, Issue:3
| Rational design of indoleamine 2,3-dioxygenase inhibitors. |
| AID443995 | Inhibition of mouse recombinant IDO expressed in mouse P815B cells assessed as blockade of tryptophan degradation by HPLC | 2010 | Journal of medicinal chemistry, Feb-11, Volume: 53, Issue:3
| Rational design of indoleamine 2,3-dioxygenase inhibitors. |
| AID1487210 | Inhibition of human IDO1 at 10 uM pre-incubated for 10 mins before L-Trp as substrate addition and measured after 30 mins by colorimetry | 2017 | Bioorganic & medicinal chemistry letters, 08-01, Volume: 27, Issue:15
| Synthesis of 4- and 5-arylthiazolinethiones as inhibitors of indoleamine 2,3-dioxygenase. |
| AID443999 | Cytotoxicity against HEK293 cells expressing human recombinant IDO by MTT assay | 2010 | Journal of medicinal chemistry, Feb-11, Volume: 53, Issue:3
| Rational design of indoleamine 2,3-dioxygenase inhibitors. |
| AID443996 | Inhibition of human recombinant IDO expressed in HEK293 cells assessed as blockade of tryptophan degradation by HPLC | 2010 | Journal of medicinal chemistry, Feb-11, Volume: 53, Issue:3
| Rational design of indoleamine 2,3-dioxygenase inhibitors. |
| AID443997 | Inhibition of mouse recombinant TDO expressed in mouse P815B cells assessed as blockade of tryptophan degradation by HPLC | 2010 | Journal of medicinal chemistry, Feb-11, Volume: 53, Issue:3
| Rational design of indoleamine 2,3-dioxygenase inhibitors. |
| AID444000 | Cytotoxicity against mouse P815B cells expressing mouse recombinant TDO by MTT assay | 2010 | Journal of medicinal chemistry, Feb-11, Volume: 53, Issue:3
| Rational design of indoleamine 2,3-dioxygenase inhibitors. |
| AID443993 | Inhibition of human recombinant IDO expressed in Escherichia coli BL21 AI | 2010 | Journal of medicinal chemistry, Feb-11, Volume: 53, Issue:3
| Rational design of indoleamine 2,3-dioxygenase inhibitors. |
| AID540299 | A screen for compounds that inhibit the MenB enzyme of Mycobacterium tuberculosis | 2010 | Bioorganic & medicinal chemistry letters, Nov-01, Volume: 20, Issue:21
| Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis. |
| AID588519 | A screen for compounds that inhibit viral RNA polymerase binding and polymerization activities | 2011 | Antiviral research, Sep, Volume: 91, Issue:3
| High-throughput screening identification of poliovirus RNA-dependent RNA polymerase inhibitors. |
| AID588501 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set | 2010 | Current protocols in cytometry, Oct, Volume: Chapter 13 | Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening. |
| AID588501 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set | 2006 | Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
| Microsphere-based protease assays and screening application for lethal factor and factor Xa. |
| AID588501 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set | 2010 | Assay and drug development technologies, Feb, Volume: 8, Issue:1
| High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors. |
| AID588497 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set | 2010 | Current protocols in cytometry, Oct, Volume: Chapter 13 | Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening. |
| AID588497 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set | 2006 | Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
| Microsphere-based protease assays and screening application for lethal factor and factor Xa. |
| AID588497 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set | 2010 | Assay and drug development technologies, Feb, Volume: 8, Issue:1
| High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors. |
| AID588499 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set | 2010 | Current protocols in cytometry, Oct, Volume: Chapter 13 | Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening. |
| AID588499 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set | 2006 | Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
| Microsphere-based protease assays and screening application for lethal factor and factor Xa. |
| AID588499 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set | 2010 | Assay and drug development technologies, Feb, Volume: 8, Issue:1
| High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors. |
| AID1745845 | Primary qHTS for Inhibitors of ATXN expression | | | |
| AID651635 | Viability Counterscreen for Primary qHTS for Inhibitors of ATXN expression | | | |
| AID504812 | Inverse Agonists of the Thyroid Stimulating Hormone Receptor: HTS campaign | 2010 | Endocrinology, Jul, Volume: 151, Issue:7
| A small molecule inverse agonist for the human thyroid-stimulating hormone receptor. |
| AID504810 | Antagonists of the Thyroid Stimulating Hormone Receptor: HTS campaign | 2010 | Endocrinology, Jul, Volume: 151, Issue:7
| A small molecule inverse agonist for the human thyroid-stimulating hormone receptor. |
| [information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] |